Recall checklist
Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21
Class 3 recall — Action within 5 days. The defect is unlikely to cause harm to the patient.
- Reference
- EL(26)A/21
- Issued
- 23 Apr 2026
- Marketing authorisation holder
- Omega Pharma Ltd
Scan for the official GOV.UK notice, or search GOV.UK for EL(26)A/21.
Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice. Printed from pharmshark.com on 4 November 2026; the notice may have changed since, so scan the QR code to check. Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.
No affected stock found
Batches as listed by the MHRA, exactly as published. Check against the GOV.UK notice before acting.
| Napralief 250mg Gastro-Resistant Tablets EL(26)A/21 | |||||
|---|---|---|---|---|---|
| Batch number | Expiry | Pack size | Packs found | Quarantined ✓ | Initials |
| B51496 | 31/10/2028 | 9 Tablets | |||
| B51497 | 31/10/2028 | 9 Tablets | |||
| B51102 | 31/07/2028 | 9 Tablets | |||
| Other packs found (write in) | |||||
|---|---|---|---|---|---|
| Product | Batch number | Expiry | Packs found | Quarantined ✓ | Initials |